Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biohaven Announces Scientific Leadership Changes | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Biohaven Announces Scientific Leadership Changes

Davird Pirman promoted to EVP and Head of Discovery; Bruce Car transitions to Chief Innovation Officer; Warren Volles designated Executive Officer.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

L to R: David Pirman, Bruce D. Car, Warren Volles.

Biohaven Ltd. has announced scientific leadership role transitions designed to accelerate drug innovation and external collaborations.

First, David Pirman, Ph.D., has been promoted to Executive Vice President and Head of Discovery, where he will lead the Company’s internal drug-discovery organization, overseeing research programs.

Meanwhile, Dr. Bruce D. Car is retiring as Chief Scientific Officer and will remain with the Company as a part-time employee in the newly created role of Chief Innovation Officer, effective July 13, 2026. In this role, Car will focus on advancing Biohaven’s scientific initiatives and external collaborations including leading multiple assets under the Company’s collaboration with Bexorg Inc. Car will also continue to serve as an executive officer of the Company.

Lastly, Warren Volles, General Counsel and Chief Legal Officer, has been designated an executive officer of Biohaven and will continue to lead the Company’s legal function.

Vlad Coric, M.D., Chairman and CEO of Biohaven, says these executive transitions “will position us to sustain our discovery momentum and pursue new CNS therapies grounded in human biology and translational innovation.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics